222 related articles for article (PubMed ID: 2167173)
1. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates.
Terres W; Umnus S; Mathey DG; Bleifeld W
Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.
Paolini R; Casonato A; Boeri G; Luzzatto G; Girolami A; Sasahara AA; Cella G
J Med; 1993; 24(2-3):113-30. PubMed ID: 8409776
[TBL] [Abstract][Full Text] [Related]
3. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit.
Ohlstein EH; Storer B; Fujita T; Shebuski RJ
Thromb Res; 1987 May; 46(4):575-85. PubMed ID: 3112993
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation.
Berridge DC; Burgess-Wilson ME; Westby JC; Hopkinson BR; Makin GS
Br J Surg; 1989 Oct; 76(10):1026-30. PubMed ID: 2513082
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator.
Yamada Y; Furui H; Furumichi T; Yamauchi K; Yokota M; Saito H
Am Heart J; 1991 Jun; 121(6 Pt 1):1618-27. PubMed ID: 1903579
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
Penny WF; Ware JA
Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
[TBL] [Abstract][Full Text] [Related]
9. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
[TBL] [Abstract][Full Text] [Related]
10. Streptokinase-induced platelet aggregation. Prevalence and mechanism.
Vaughan DE; Van Houtte E; Declerck PJ; Collen D
Circulation; 1991 Jul; 84(1):84-91. PubMed ID: 2060126
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic agents inhibit platelet adhesion onto collagen type I-coated surfaces at high blood flow conditions.
Huang TC; Graham DA; Nelson LD; Alevriadou BR
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):213-26. PubMed ID: 9663703
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator inhibits aggregation of platelets in vitro.
Mizuta T; Imai C
Life Sci; 1988; 43(12):955-63. PubMed ID: 3139948
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.
Fears R; Ferres H; Greenwood HC
Thromb Res; 1990 Nov; 60(4):259-68. PubMed ID: 2128420
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
16. Streptokinase, but not tissue plasminogen activator, attenuates platelet aggregation in patients with acute myocardial infarction.
Karlberg KE; Chen J; Hagerman I; Bergström K; Wallin R; Saldeen T; Sylvén C
J Intern Med; 1993 Nov; 234(5):513-9. PubMed ID: 8228797
[TBL] [Abstract][Full Text] [Related]
17. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
Rudd MA; George D; Amarante P; Vaughan DE; Loscalzo J
Circ Res; 1990 Nov; 67(5):1175-81. PubMed ID: 2146037
[TBL] [Abstract][Full Text] [Related]
18. Lytic solution of platelet-rich plasma clots potentiated platelet response to agonists by action on Ca2+ homeostasis.
Liao CL; Zou QJ
Zhongguo Yao Li Xue Bao; 1993 May; 14(3):214-8. PubMed ID: 8237394
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
Gao SW; Morser J; McLean K; Shuman MA
Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
[TBL] [Abstract][Full Text] [Related]
20. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis.
Terres W; Beythien C; Kupper W; Bleifeld W
Circulation; 1989 Jun; 79(6):1309-14. PubMed ID: 2720929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
